dextroamphetamine (Dexedrine) Report issue

Small molecule Approved FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem repoDB

Active Ingredient History

NOW
  • Now
DEXTROAMPHETAMINE TANNATE is a salt of dextroamphetamine, amphetamine enantiomer. It is used as CNS stimulant in the treatment of attention deficit hyperactivity disorder.   NCATS

Chemistry

More Chemistry

Pharmacology

Drug Pricing (per unit)

United States

$0.0462 - $17.5416
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Combination drugs

( amphetamine (Adderall), dextroamphetamine (Dexedrine) - other names: adderall, adderall xr, dextroamp saccharate, amp aspartate, dextroamp sulfate and amp sulfate, dextroamp saccharate,amp aspartate,dextroamp sulfate and amp sulfate, mydayis )

Alternative names

amphetamine sulfate, dextro | d amphetamine | d-amphetamine | d-amphetamine saccharate | d-amphetamine sulfate | d-deoxyephedrine | d-desoxyephedrine | desoxynorephedrine | dexadrine | dexamfetamine | dexamfetamine sulphate | dexampex | dexamphetamine | dexedrine | dextroamphetamine | dextro amphetamine | dextro-amphetamine | dextroamphetamine adipate | dextroamphetamine resin complex | dextroamphetamine saccharate | dextro-amphetamine sulfate | dextroamphetamine sulfate | dextromethamphetamine | dextrostat | dl-amphetaminil | ferndex | hld100

Organizations (60)

Research & Development (14)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (46)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (14)

Approved Indications (3)


 

Aortic Valve Insufficiency

Attention Deficit Disorder with Hyperactivity

Narcolepsy

Experimental Indications - Clinical Trial Phases 1-4 (13)


 

Affect (Phase 2)

Attention Deficit and Disruptive Behavior Disorders (Phase 2)

Attention Deficit Disorder with Hyperactivity ()

Bipolar Disorder (Phase 1)

Central Nervous System Stimulants (Phase 4)

Cocaine-Related Disorders (Early Phase 1)

Deception (Phase 4)

Fetal Alcohol Spectrum Disorders (Phase 4)

Healthy Volunteers (Phase 3)

Idiopathic Hypersomnia (Phase 2)

Memory, Short-Term (Phase 2)

Motivation (Phase 4)

Narcolepsy (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 13
  • # of Trial Organizations: 14

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue